BOSTON — Sware has launched the latest version of its intelligent GxP validation platform, Res_Q, introducing new AI-driven capabilities to help life sciences organizations streamline compliance, accelerate digital transformation, and strengthen operational efficiency. The enhanced platform combines advanced machine intelligence with deep regulatory expertise, aligning with the FDA’s growing support for artificial intelligence in modern regulatory frameworks.
“Life sciences leaders deserve tools that shift the focus from endless administrative hurdles to real scientific advancement,” said Ellen Reilly, chief executive officer of Sware. “The new Res_Q delivers that by layering intelligent AI onto our proven foundation, optimizing workflows and strengthening risk management in a space moving at breakneck speed. For IT, Quality, and Digital Transformation leaders, it’s a straightforward path to validation that accelerates innovation, builds confidence, and delivers measurable business value.”
The upgraded Res_Q platform introduces powerful new AI features designed to simplify validation and compliance. Smart Analytics and Dashboards provide clear, data-driven insights to optimize processes and improve operational visibility. Instant Processing automatically converts vendor manuals, protocols, and validation packages into structured, searchable documents within minutes, reducing manual workloads. A new Video-to-Script Conversion tool transforms video content into structured, audit-ready documentation, improving accessibility and compliance readiness.
Sware plans to roll out additional AI-enabled capabilities in upcoming releases to further expand the platform’s efficiency and adaptability. The update also strengthens existing features, including real-time visibility into validation workloads, automated risk assessments aligned with modern regulatory imperatives such as Computer Software Assurance, and seamless API integrations with enterprise systems.
The platform’s continued innovation is supported by Sware’s two decades of leadership in compliance technology. In April 2025, Sware announced a partnership with Salesforce to provide GxP computer system validation for Salesforce Life Sciences Cloud users through Res_Q.
“Our partnership with Sware offers Salesforce Life Sciences Cloud users a compelling way to embed robust, efficient, and scalable GxP validation directly into their cloud environment,” said Frank Defesche, senior vice president and general manager, Life Sciences at Salesforce. “This helps our customers focus on groundbreaking work instead of compliance logistics.”
Earlier this year, Sware was also named Box’s 2025 Life Sciences Partner of the Year for its integration supporting GxP compliance through Box content management systems, further demonstrating its leadership in advancing intelligent, compliant digital transformation across the life sciences industry.
